---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-002918"
form_type: "8-K"
ticker: "IMDX"
cik: "0001642380"
company_name: "Insight Molecular Diagnostics Inc."
filed_at: "2023-01-30T23:59:59+00:00"
generated_at: "2026-06-20T06:38:08.917142+00:00"
event_type: "regulatory"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Oncocyte applies to transfer Nasdaq listing to Capital Market to cure bid price deficiency

## Summary
- Applied on Jan 24, 2023 to transfer listing from Nasdaq Global Market to Nasdaq Capital Market.
- Transfer expected to allow additional 180-day compliance period for minimum bid price requirement.
- Common stock to continue trading under symbol "OCX" after transfer.
- Previously received Nasdaq deficiency notice on Aug 9, 2022 for bid price below $1.00 for 30 consecutive days.

## SEC filing metadata
- accession: 0001493152-23-002918
- form_type: 8-K
- ticker: IMDX
- cik: 0001642380
- company_name: Insight Molecular Diagnostics Inc.
- filed_at: 2023-01-30T23:59:59+00:00
- event_type: regulatory
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1642380/000149315223002918/0001493152-23-002918-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1642380/000149315223002918/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-002918
- JSON: https://secwatch.observer/filing/0001493152-23-002918.json
- Plain text: https://secwatch.observer/filing/0001493152-23-002918.txt

## Key facts
- Listing & Compliance Notices
  Insight Molecular Diagnostics Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5450(a)(1), 5810(c)(3)(A)(ii)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: late filing
  - Rules: 5450(a)(1), 5810(c)(3)(A)(ii)
  source text: August 9, 2022 indicating that Nasdaq had determined that the Company no longer meets the minimum bid price requirement of Nasdaq Listing Rule 5450(a)(1), as the minimum closing bid price for the Company’s common stock was less than $1.00 for the previous 30 consecutive business days. The Notice provided that the Company may consider applying to transfer the listing of the Company’s common stock to The Nasdaq Capital Market, subject to the Company submitting an online transfer application, paying the requisite fee, satisfying such market’s continued listing requirement for the market value of
  evidence_url: https://www.sec.gov/Archives/edgar/data/1642380/000149315223002918/0001493152-23-002918-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.